Replies to post #24010 on The Golden Lounge

[SSP]

WREXE - PRE 14C filed on 02/24/2004

 
  
  
 WILMINGTON REXFORD, INC. 
                       3753 HOWARD HUGHES PARKWAY, SUITE 200 
                              LAS VEGAS, NEVADA 89109 
  
                               INFORMATION STATEMENT 
  
                                  MARCH __, 2004 
  
  
 This Information Statement is being furnished to stockholders of Wilmington 
 Rexford, Inc., a Delaware corporation (the "Company"), to advise them of 
 corporate actions approved without a meeting by less than unanimous written 
 consent of stockholders. These actions are (a) the adoption of amendments to the 
 Company's Certificate of Incorporation (the "Charter Amendments") to (i) change 
 the name of the Company from Wilmington Rexford, Inc., to China Pharmaceuticals 
 Corporation; (ii) authorize 30,000,000 additional shares of common stock, 
 $0.0001 par value per share; and (iii) effect a 20:1 reverse stock split (the 
 "Reverse Stock Split").